Semaglutide Sodium (Rybelsus, Ozempic, NN9535, OG217SC, NNC 0113-0217), a long-acting glucagon-like peptide 1 (GLP-1) analogue, is a GLP-1 receptor agonist with the potential for the treatment of type 2 diabetes mellitus (T2DM)
Beverages Yerba Mate Market Yerba Mate Market Size, Share, and Growth Forecast, 2026 - 2033 Yerba Mate Market by Form (Powder, Loose Leaf, Liquid Concentrate), Application (Food & Beverages, Dietary Supplements, Cosmetics & Personal Care), Nature (Organic, Conventional), and Regional Analysis for 2026-2033 December 2025 215 Pages Author : Amol Patil Yerba Mate Market Share and Trends Analysis The global y erba mate market size is likely to be valued at US$ 2.1 billion in 2026 , and is projected to reach US$ 3.0 billion by 2033 , growing at a CAGR of 5.2% during the forecast period 20262033
Semaglutide fits into this approach because it offers a tool for managing weight over time, not just for a few months
Systematic reviews and meta-analyses have found that probiotic supplementation may modestly improve glycaemic parameters and support weight management in people with type 2 diabetes, though results are inconsistent across studies, with generally small effect sizes